314 Mutational landscape and significance across 12 major cancer types.
http://www.nature.com/nature/journal/v502/n7471/full/nature12634.html
313 Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells.
http://www.nature.com/srep/2013/131016/srep02953/full/srep02953.html
312 Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
http://www.pnas.org/content/110/41/16580.abstract
311 Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy.
http://pubs.acs.org/doi/abs/10.1021/nn403606m
310 Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2733.html
309 The integrated landscape of driver genomic alterations in glioblastoma.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2734.html
308 Emerging landscape of oncogenic signatures across human cancers.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2762.html
307 Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2761.html
306 The Cancer Genome Atlas Pan-Cancer analysis project.
http://www.nature.com/ng/journal/v45/n10/abs/ng.2764.html
305 Cell motility and drug gradients in the emergence of resistance to chemotherapy.
http://www.pnas.org/content/110/40/16103.abstract
304 Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.
http://www.pnas.org/content/110/40/15919.abstract
303 Activity of receptor tyrosine kinase networks may serve as an effective means to classify breast cancers and predict their sensitivity to therapeutic drugs.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;6/294/ra84
302 Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2.
http://www.cell.com/immunity/abstract/S1074-7613(13)00377-4
301 Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer.
http://www.nature.com/nchembio/journal/v9/n10/abs/nchembio.1331.html
300 Immunity against phosphopeptide antigens lacking in leukemia patients can be restored with stem cell transplantation.
http://stm.sciencemag.org/content/5/203/203ra125.abstract
299 Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
http://www.pnas.org/content/110/38/E3640.abstract
298 Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2.
http://www.pnas.org/content/110/38/15389.abstract
297 Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy.
http://www.pnas.org/content/110/38/15189.abstract
296 TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis.
http://www.cell.com/molecular-cell/abstract/S1097-2765(13)00540-6
295 Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00355-3
|
